Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | GSK | REGN | ||
| Company | Celgene Corp | Gsk Plc ADR | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 108.01 | 49.47 | 600.79 | ||
| High | 108.59 | 49.89 | 625.00 | ||
| Low | 107.27 | 49.39 | 599.00 | ||
| Latest | 108.24 | 49.72 | 618.95 | ||
| Change | +0.11 | +0.72 | +16.03 | ||
| % Change | +0.10% | +1.47% | +2.66% | ||
| Volume | 191,230,496 | 3,811,734 | 985,460 | ||
| 20-Day Average Volume | 16,188,930 | 3,413,487 | 1,183,473 | ||
| Previous Close | 108.13 | 49.00 | 602.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 50.58 | 661.23 | ||
| 20-Day Raw Stochastic | 63.25% | 32.49% | 19.72% | ||
| 20-Day Relative Strength | 64.69 | 39.92 | 34.73 | ||
| Weighted Alpha | +46.30 | +16.42 | +9.95 | ||
| Today's Opinion | 100% Buy | 24% Sell | 72% Sell | ||
| Previous Opinion | 100% Buy | 40% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -3.61% since 05/27/26 | -1.40% since 05/27/26 | ||
| Low | 107.27 on 11/20/19 | 48.57 on 06/02/26 | 591.52 on 06/02/26 | ||
| High | 110.53 on 11/14/19 | 51.94 on 05/28/26 | 631.73 on 05/28/26 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | -3.66% since 05/01/26 | -11.76% since 05/01/26 | ||
| Low | 102.40 on 10/21/19 | 48.57 on 06/02/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 52.11 on 05/27/26 | 730.59 on 05/13/26 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -12.88% since 03/03/26 | -19.27% since 03/03/26 | ||
| Low | 93.41 on 08/23/19 | 48.57 on 06/02/26 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 59.57 on 04/14/26 | 791.60 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +1.53% since 12/03/25 | -14.47% since 12/03/25 | ||
| Low | 89.08 on 07/23/19 | 47.20 on 12/09/25 | 591.52 on 06/02/26 | ||
| High | 110.70 on 11/13/19 | 61.69 on 02/18/26 | 821.11 on 01/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 99,430,704 | 63,740,700 | ||
| Shares Outstanding, K | 711,714 | 2,029,198 | 105,720 | ||
| Annual Sales | 15,281,000,000 | 43,077,970,000 | 14,342,900,000 | ||
| Annual Net Income | 4,046,000,000 | 7,537,690,000 | 4,504,900,000 | ||
| Last Quarter Sales | 4,520,000,000 | 10,280,080,000 | 3,605,400,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 2,340,610,000 | 727,200,000 | ||
| 60-Month Beta | 1.41 | 0.36 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 1.24 on 04/29/26 | 9.47 on 04/29/26 | ||
| Earnings Date | 01/30/20 | 07/29/26 | 08/07/26 | ||
| Most Recent Dividend | N/A | 0.454 on 05/15/26 | 0.940 on 05/20/26 | ||
| Next Ex-Dividends Date | N/A | 05/15/26 | 05/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 10.65 | 16.17 | ||